[发明专利]百合总皂苷在防治细胞线粒体损伤相关的疾病中的用途

权利要求书

1.百合总皂苷在制备防治细胞线粒体损伤相关的疾病的产品中的用途。

2.根据权利要求1所述的用途，其特征在于，所述百合总皂苷的成分包括：王百合苷A、王百合苷B和/或其同分异构体、王百合苷C、王百合苷D、王百合苷E、王百合苷F、6'-O-feruloylsucrose、1-O-P-coumaroyl glycerol、2,4,6-trichlorol-3-methyl-5-methoxy-phenol1-O-β-D-glucopyranosyl-(1→6)-β-D-glucopyranoside、tenuifoliol3-O-[β-D-glucopyranosyl-(1→4)]-β-D-glucopyranoside、3-O-α-L-rhamnopyranosyl-(1→2)-O-[β-D-glucopyranosyl-(1→4)]-β-D-glucopy ranoside、26-O-β-D-glucopyranosyl-(25R)-5α-furostan-3β,22ξ-diol3-O-α-L-rhamnopyranosyl-(1→2)-O-[β-D-glucopyranosyl-(1→4)]-β-D-glucopy ranoside、(25S)-spirost-5-ene-3β,27-diol3-O-{α-L-rhamnopyranosyl-(1→2)-[β-D-glucopyranosyl-(186)]}-β-D-glucopyranoside、(25R)-5α-spirostan-3β,12α-diol3-O-α-L-rhamnopyranosyl-(1→2)-O-[β-D-glucopyranosyl-(1→4)]-β-D-glucopy ranoside和/或其同分异构体、Isonarthogenin3-O-{O-β-D-glucopyranosyl-(1→3)-O-α-L-rhamnopyranosyl-(1→2)-O-[β-D-glucopyranosyl-(1→4)]-β-D-glucopyranoside}、26-O-β-D-glucopyranosyl-(25R)-5α-furost-5-en-3β,22ξ-diol3-O-α-L-rhamnopyranosyl-(1→2)-O-[β-D-glucopyranosyl-(1→4)]-β-D-glucopy ranoside、(25S)-spirost-5-ene-3β,27-diol3-O-{α-L-rhamnopyranosyl-(1→2)-[β-D-glucopyranosyl-(1→4)]}-β-D-glucopy ranoside、(25R)-27-O-[(S)-3-hydroxy-3-methylglutaroyl]-spirost-5-ene-3β,27-diol 3-O-α-L-rhamnopyranosyl-(l→2)-O-[β-D-glucopyranosyl-(1→3)]-β-D-glucopyranoside和/或其同分异构体、(25R,26R)-26-methoxyspirost-5-en-3β-ol3-O-α-L-rhamnopyranosyl-(1→2)-O-[α-L-arabinopyranosyl-(1→3)]-β-D-gluco pyranoside和/或其同分异构体、(25R)-3β-hydroxyl-5α-spirost-6-heptanone-3-O-α-L-rhamnopyranosyl-(1→2)-β-D-glucopyranoside和/或其同分异构体、(25R)-3β,17α-2-hydroxyl-5α-spirost-6-heptanone-3-O-α-L-rhamnopyranosyl-(l→2)-β-D-glucopyranoside、(25R)-27-O-(3-hydroxy-3-methylglutaroyl)-spirost-5-en-3β,27-diol3-O-[x-L-rhamnopyranosyl(l→2)]-β-D-glucopy-ranoside和(25R,26R)-3β-{β-D-glucopyranosyl-(1→4)-[α-L-rhamnopyranosyl-(1→2)]-β-D-glucopyranosyloxy}-26-ethoxy-spirost-5-ene。